Please provide your email address to receive an email when new articles are posted on . Among patients with T1 colorectal cancer, deep submucosal invasion was not a significant independent predictor ...
Submucosal fibroids are benign tumors that can cause heavy menstrual bleeding. Hormonal fluctuations and family history can increase the chance of having fibroids. People with severe vaginal bleeding ...
Endoscopic submucosal dissection (ESD) represents a significant advance in therapeutic endoscopy with the major advantage being the ability to achieve a higher en bloc resection rate for early stage ...
More than 10 years have passed since endoscopic submucosal dissection (ESD) was first developed in Japan. ESD enables en bloc complete resection of superficial gastrointestinal neoplasms regardless of ...
Baylor College of Medicine’s Submucosal/Transluminal Fellowship is a one-year program that provides mentored career development in third space and transluminal endoscopy. Trainees will receive ...
A phase II, open-label, randomized study to evaluate the efficacy and safety of andecaliximab combined with nivolumab versus nivolumab alone in subjects with unresectable or recurrent gastric or ...
The saline-immersion/irrigation technique (SITE) in colorectal endoscopic submucosal dissection (ESD), combined with the pocket-creation method (PCM), showed curative ...
Researchers examine curcumin's therapeutic power against oral submucosal fibrosis, revealing its potential to reduce inflammation, fibrosis, and cancer risks in this precancerous oral condition. Study ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--EndoClot Plus, Inc. (EPI), a privately held medical device company announced the FDA 510(k) clearance of EndoClot ® Submucosal Injection Agent (EndoClot ® SIA) ...